
Marcia Stephens Noble
Examiner (ID: 19297, Phone: (571)272-5545 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 1089 |
| Issued Applications | 595 |
| Pending Applications | 110 |
| Abandoned Applications | 393 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14072113
[patent_doc_number] => 20190084944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => COMPOUNDS FOR INDUCING PROLIFERATION AND DIFFERENTIATION OF CELLS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/135468
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16135468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/135468 | Compounds for inducing proliferation and differentiation of cells, and methods of use thereof | Sep 18, 2018 | Issued |
Array
(
[id] => 17220177
[patent_doc_number] => 11172657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Method for developing organ that lacks specific functional cell
[patent_app_type] => utility
[patent_app_number] => 16/638440
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 5285
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638440
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638440 | Method for developing organ that lacks specific functional cell | Sep 17, 2018 | Issued |
Array
(
[id] => 19274611
[patent_doc_number] => 12024722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Methods for reprogramming cells and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/125528
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67893
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125528
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/125528 | Methods for reprogramming cells and uses thereof | Sep 6, 2018 | Issued |
Array
(
[id] => 16414518
[patent_doc_number] => 10822394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Method of producing recombinant high molecular weight vWF in cell culture
[patent_app_type] => utility
[patent_app_number] => 16/125141
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 41872
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125141
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/125141 | Method of producing recombinant high molecular weight vWF in cell culture | Sep 6, 2018 | Issued |
Array
(
[id] => 13987155
[patent_doc_number] => 20190062735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => CRISPR-CPF1-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/121152
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/121152 | Crispr-CPF1-related methods, compositions and components for cancer immunotherapy | Sep 3, 2018 | Issued |
Array
(
[id] => 13986467
[patent_doc_number] => 20190062391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => USE OF VEGF-B FOR TREATING DISEASES INDUCED BY OXIDATIVE INJURY
[patent_app_type] => utility
[patent_app_number] => 16/118488
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16118488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/118488 | USE OF VEGF-B FOR TREATING DISEASES INDUCED BY OXIDATIVE INJURY | Aug 30, 2018 | Abandoned |
Array
(
[id] => 13982493
[patent_doc_number] => 20190060404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => USE OF VEGF-B FOR TREATING DISEASES INVOLVING NEOANGIOGENESIS
[patent_app_type] => utility
[patent_app_number] => 16/118486
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16118486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/118486 | USE OF VEGF-B FOR TREATING DISEASES INVOLVING NEOANGIOGENESIS | Aug 30, 2018 | Abandoned |
Array
(
[id] => 13987081
[patent_doc_number] => 20190062698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => DERIVATION OF EMBRYONIC STEM CELLS AND EMBRYO-DERIVED CELLS
[patent_app_type] => utility
[patent_app_number] => 16/113839
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16113839
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/113839 | DERIVATION OF EMBRYONIC STEM CELLS AND EMBRYO-DERIVED CELLS | Aug 26, 2018 | Abandoned |
Array
(
[id] => 13958353
[patent_doc_number] => 20190055520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => METHOD OF DIFFERENTIATING HUMAN PLURIPOTENT STEM CELLS TO PODOCYTES
[patent_app_type] => utility
[patent_app_number] => 16/105397
[patent_app_country] => US
[patent_app_date] => 2018-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16105397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/105397 | Method of differentiating human pluripotent stem cells to podocytes | Aug 19, 2018 | Issued |
Array
(
[id] => 14625139
[patent_doc_number] => 20190225937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => BANK OF STEM CELLS FOR PRODUCING CELLS FOR TRANSPLANTATION HAVING HLA ANTIGENS MATCHING THOSE OF TRANSPLANT RECIPIENTS AND METHODS FOR MAKING AND USING SUCH A STEM CELL BANK
[patent_app_type] => utility
[patent_app_number] => 16/102640
[patent_app_country] => US
[patent_app_date] => 2018-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16102640
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/102640 | BANK OF STEM CELLS FOR PRODUCING CELLS FOR TRANSPLANTATION HAVING HLA ANTIGENS MATCHING THOSE OF TRANSPLANT RECIPIENTS AND METHODS FOR MAKING AND USING SUCH A STEM CELL BANK | Aug 12, 2018 | Abandoned |
Array
(
[id] => 16506424
[patent_doc_number] => 20200385680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => IMMORTALIZED SWEAT GLAND MYOEPITHELIAL CELL
[patent_app_type] => utility
[patent_app_number] => 16/626052
[patent_app_country] => US
[patent_app_date] => 2018-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626052 | Immortalized sweat gland myoepithelial cell | Aug 6, 2018 | Issued |
Array
(
[id] => 17587890
[patent_doc_number] => 11326148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Methods of differentiating stem cell-derived ectodermal lineage precursors
[patent_app_type] => utility
[patent_app_number] => 16/054071
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 117
[patent_no_of_words] => 30682
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054071
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054071 | Methods of differentiating stem cell-derived ectodermal lineage precursors | Aug 2, 2018 | Issued |
Array
(
[id] => 13871491
[patent_doc_number] => 20190032086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => METHOD FOR PREPARING A GENE KNOCK-OUT CANINE WITH SOMATIC CELL CLONING TECHNOLOGY
[patent_app_type] => utility
[patent_app_number] => 16/045683
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/045683 | METHOD FOR PREPARING A GENE KNOCK-OUT CANINE WITH SOMATIC CELL CLONING TECHNOLOGY | Jul 24, 2018 | Abandoned |
Array
(
[id] => 14360623
[patent_doc_number] => 10301599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Methods and products for transfection
[patent_app_type] => utility
[patent_app_number] => 16/037597
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 18713
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16037597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/037597 | Methods and products for transfection | Jul 16, 2018 | Issued |
Array
(
[id] => 15055253
[patent_doc_number] => 10457917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Methods for reprogramming somatic cells
[patent_app_type] => utility
[patent_app_number] => 16/030815
[patent_app_country] => US
[patent_app_date] => 2018-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10831
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16030815
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/030815 | Methods for reprogramming somatic cells | Jul 8, 2018 | Issued |
Array
(
[id] => 13826561
[patent_doc_number] => 20190016765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => ENDOPLASMIC RETICULUM LOCALIZATION SIGNALS
[patent_app_type] => utility
[patent_app_number] => 16/014124
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014124
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/014124 | ENDOPLASMIC RETICULUM LOCALIZATION SIGNALS | Jun 20, 2018 | Abandoned |
Array
(
[id] => 13493567
[patent_doc_number] => 20180298326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => METHOD OF NOCICEPTOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/014765
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/014765 | METHOD OF NOCICEPTOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND USES THEREOF | Jun 20, 2018 | Abandoned |
Array
(
[id] => 16756817
[patent_doc_number] => 10975357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Methods and compositions related to differentiated lung cells
[patent_app_type] => utility
[patent_app_number] => 16/011809
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 69
[patent_no_of_words] => 40924
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011809
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011809 | Methods and compositions related to differentiated lung cells | Jun 18, 2018 | Issued |
Array
(
[id] => 13778759
[patent_doc_number] => 20190002918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => DONOR PLASMID VECTORS
[patent_app_type] => utility
[patent_app_number] => 16/012686
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/012686 | Donor plasmid vectors | Jun 18, 2018 | Issued |
Array
(
[id] => 13573861
[patent_doc_number] => 20180338479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => TRANSGENIC ANIMAL FOR PRODUCTION OF ANTIBODIES HAVING MINIMAL CDRS
[patent_app_type] => utility
[patent_app_number] => 15/996373
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996373
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996373 | Transgenic animal for production of antibodies having minimal CDRS | May 31, 2018 | Issued |